APA (7th ed.) Citation

Robertson, J. F., Cheung, K., Noguchi, S., Shao, Z., Degboe, A., Lichfield, J., . . . Ellis, M. J. (2018). Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer. Elsevier.

Chicago Style (17th ed.) Citation

Robertson, John F.R., Kwok-Leung Cheung, Shinzaburo Noguchi, Zhimin Shao, Arnold Degboe, Jasmine Lichfield, Jackie Thirlwell, Mehdi Fazal, and Matthew J. Ellis. Health-related Quality of Life from the FALCON Phase III Randomised Trial of Fulvestrant 500 Mg Versus Anastrozole for Hormone Receptor-positive Advanced Breast Cancer. Elsevier, 2018.

MLA (9th ed.) Citation

Robertson, John F.R., et al. Health-related Quality of Life from the FALCON Phase III Randomised Trial of Fulvestrant 500 Mg Versus Anastrozole for Hormone Receptor-positive Advanced Breast Cancer. Elsevier, 2018.